Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck’s Jay Galeota Joins G&W Laboratories

Executive Summary

Jay Galeota , Merck & Co’s former chief strategy and business development officer and president of emerging businesses, has been appointed president and chief operating officer of G&W Laboratories. He will take over the role from current president Kurt Orlofski, who will assume the newly created position of president of generics. Prior to joining G&W, Galeota spent 28 years at Merck, working both in the US and globally and helping to establish the Merck Global Health Fund and Innovative Venture Group, as well as leading the development and launching of Merck’s top-grossing products, Januvia and Janumet.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts